DrugPatentWatch Database Preview
Details for Patent: 8,227,484
Which drugs does patent 8,227,484 protect, and when does it expire?
Patent 8,227,484 protects NUEDEXTA and is included in one NDA.
This patent has sixty-eight patent family members in twenty-one countries.
Summary for Patent: 8,227,484
| Title: | Pharmaceutical compositions comprising dextromethorphan and quinidine for the treatment of neurological disorders |
| Abstract: | Pharmaceutical compositions and methods for treating neurological disorders by administering same are provided. The compositions comprise dextromethorphan in combination with quinidine. |
| Inventor(s): | Yakatan; Gerald (Del Mar, CA), Berg; James (San Diego, CA), Pope; Laura (Carlsbad, CA), Smith; Richard Alan (La Jolla, CA) |
| Assignee: | Avanir Pharmaceuticals, Inc. (Aliso Viejo, CA) |
| Application Number: | 13/415,067 |
| Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for patent 8,227,484 |
|
Patent Claim Types: see list of patent claims | Use; |
Drugs Protected by US Patent 8,227,484
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Avanir Pharms | NUEDEXTA | dextromethorphan hydrobromide; quinidine sulfate | CAPSULE;ORAL | 021879-001 | Oct 29, 2010 | AB | RX | Yes | Yes | Start Trial | Start Trial | TREATMENT OF PSEUDOBULBAR AFFECT | Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 8,227,484
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Austria | 399553 | Start Trial | |||
| Australia | 2003251971 | Start Trial | |||
| Australia | 2008201775 | Start Trial | |||
| Australia | 2010212348 | Start Trial | |||
| Australia | 2013202184 | Start Trial | |||
| Australia | 2013202187 | Start Trial | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
